vs
Side-by-side financial comparison of Ballard Power Systems Inc. (BLDP) and Kymera Therapeutics, Inc. (KYMR). Click either name above to swap in a different company.
Ballard Power Systems Inc. is the larger business by last-quarter revenue ($17.7M vs $11.5M, roughly 1.5× Kymera Therapeutics, Inc.). Ballard Power Systems Inc. runs the higher net margin — 994.4% vs -667.6%, a 1662.0% gap on every dollar of revenue.
Ballard Power Systems Inc. is a developer and manufacturer of proton exchange membrane (PEM) fuel cell products for markets such as heavy-duty motive, portable power, material handling as well as engineering services. Ballard has designed and shipped over 400 MW of fuel cell products to date.
Kymera Therapeutics is a clinical-stage biopharmaceutical company specialized in developing innovative targeted protein degradation therapies. It advances a diversified pipeline of drug candidates targeting previously undruggable proteins to address unmet medical needs in oncology, autoimmune and inflammatory diseases worldwide.
BLDP vs KYMR — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $17.7M | $11.5M |
| Net Profit | $176.5M | $-76.6M |
| Gross Margin | — | — |
| Operating Margin | — | -736.8% |
| Net Margin | 994.4% | -667.6% |
| Revenue YoY | — | -55.3% |
| Net Profit YoY | — | -82.1% |
| EPS (diluted) | — | $-0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $17.7M | — | ||
| Q2 25 | — | $11.5M | ||
| Q1 25 | — | $22.1M | ||
| Q4 24 | — | $7.4M | ||
| Q3 24 | $-12.3M | — | ||
| Q2 24 | — | $25.6M | ||
| Q1 24 | — | $10.3M | ||
| Q4 23 | — | $47.9M |
| Q3 25 | $176.5M | — | ||
| Q2 25 | — | $-76.6M | ||
| Q1 25 | — | $-65.6M | ||
| Q4 24 | — | $-70.8M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-42.1M | ||
| Q1 24 | — | $-48.6M | ||
| Q4 23 | — | $-14.4M |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 156.5% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | -736.8% | ||
| Q1 25 | — | -336.8% | ||
| Q4 24 | — | -1092.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -198.5% | ||
| Q1 24 | — | -562.2% | ||
| Q4 23 | — | -40.3% |
| Q3 25 | 994.4% | — | ||
| Q2 25 | — | -667.6% | ||
| Q1 25 | — | -296.7% | ||
| Q4 24 | — | -956.9% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -164.0% | ||
| Q1 24 | — | -472.0% | ||
| Q4 23 | — | -30.0% |
| Q3 25 | — | — | ||
| Q2 25 | — | $-0.95 | ||
| Q1 25 | — | $-0.82 | ||
| Q4 24 | — | $-0.89 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-0.58 | ||
| Q1 24 | — | $-0.69 | ||
| Q4 23 | — | $-0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $335.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $971.5M |
| Total Assets | — | $1.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | — | ||
| Q2 25 | — | $335.8M | ||
| Q1 25 | — | $90.0M | ||
| Q4 24 | — | $120.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $67.6M | ||
| Q1 24 | — | $93.5M | ||
| Q4 23 | — | $110.0M |
| Q3 25 | — | — | ||
| Q2 25 | — | $971.5M | ||
| Q1 25 | — | $786.2M | ||
| Q4 24 | — | $835.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $684.9M | ||
| Q1 24 | — | $711.2M | ||
| Q4 23 | — | $395.0M |
| Q3 25 | — | — | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $918.3M | ||
| Q4 24 | — | $978.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $826.0M | ||
| Q1 24 | — | $868.3M | ||
| Q4 23 | — | $575.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.7M | $-59.9M |
| Free Cash FlowOCF − Capex | — | $-60.6M |
| FCF MarginFCF / Revenue | — | -527.9% |
| Capex IntensityCapex / Revenue | — | 6.1% |
| Cash ConversionOCF / Net Profit | 0.03× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-250.5M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $5.7M | — | ||
| Q2 25 | — | $-59.9M | ||
| Q1 25 | — | $-79.2M | ||
| Q4 24 | — | $-61.8M | ||
| Q3 24 | $-6.6M | — | ||
| Q2 24 | — | $-42.9M | ||
| Q1 24 | — | $-39.6M | ||
| Q4 23 | — | $8.0M |
| Q3 25 | — | — | ||
| Q2 25 | — | $-60.6M | ||
| Q1 25 | — | $-79.6M | ||
| Q4 24 | — | $-62.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-47.6M | ||
| Q1 24 | — | $-47.0M | ||
| Q4 23 | — | $-3.6M |
| Q3 25 | — | — | ||
| Q2 25 | — | -527.9% | ||
| Q1 25 | — | -360.3% | ||
| Q4 24 | — | -848.3% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -185.7% | ||
| Q1 24 | — | -456.8% | ||
| Q4 23 | — | -7.5% |
| Q3 25 | — | — | ||
| Q2 25 | — | 6.1% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 12.7% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 18.3% | ||
| Q1 24 | — | 72.0% | ||
| Q4 23 | — | 24.3% |
| Q3 25 | 0.03× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
